{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T01:37:42Z","timestamp":1781833062332,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,12]]},"DOI":"10.7759\/cureus.45136","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T23:49:01Z","timestamp":1694562541000},"source":"Crossref","is-referenced-by-count":4,"title":["Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease"],"prefix":"10.7759","author":[{"given":"Calvin W","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie A","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell  A","family":"Watsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison L","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Chronic graft-versus-host disease","volume":"5","author":"Atkinson K","year":"1990","unstructured":"Atkinson K. Chronic graft-versus-host disease. Bone Marrow Transplant. 1990, 5:69-82.","journal-title":"Bone Marrow Transplant"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-198901000-00012","article-title":"Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease","volume":"47","author":"Ferrara JL","year":"1989","unstructured":"Ferrara JL, Guillen FJ, van Dijken PJ, Marion A, Murphy GF, Burakoff SJ. Evidence that large granular lymphocytes of donor origin mediate acute graft-versus-host disease. Transplantation. 1989, 47:50-4. 10.1097\/00007890-198901000-00012","journal-title":"Transplantation"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0161-6420(83)34604-2","article-title":"Ocular manifestations of graft-vs-host disease","volume":"90","author":"Franklin RM","year":"1983","unstructured":"Franklin RM, Kenyon KR, Tutschka PJ, Saral R, Green WR, Santos GW. Ocular manifestations of graft-vs-host disease. Ophthalmology. 1983, 90:4-13. 10.1016\/s0161-6420(83)34604-2","journal-title":"Ophthalmology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-87-6-707","article-title":"Scleroderma, Sj\u00f6gren-like syndrome, and chronic graft-versus-host disease","volume":"87","author":"Lawley TJ","year":"1977","unstructured":"Lawley TJ, Peck GL, Moutsopoulos HM, Gratwohl AA, Deisseroth AB. Scleroderma, Sj\u00f6gren-like syndrome, and chronic graft-versus-host disease. Ann Intern Med. 1977, 87:707-9. 10.7326\/0003-4819-87-6-707","journal-title":"Ann Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-87-6-703","article-title":"Sj\u00f6gren-type syndrome after allogeneic bone-marrow transplantation","volume":"87","author":"Gratwohl AA","year":"1977","unstructured":"Gratwohl AA, Moutsopoulos HM, Chused TM, Akizuki M, Wolf RO, Sweet JB, Deisseroth AB. Sj\u00f6gren-type syndrome after allogeneic bone-marrow transplantation. Ann Intern Med. 1977, 87:703-6. 10.7326\/0003-4819-87-6-703","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1994.01090150102031","article-title":"The eye in bone marrow transplantation. VI. retinal complications","volume":"112","author":"Coskuncan NM","year":"1994","unstructured":"Coskuncan NM, Jabs DA, Dunn JP, Haller JA, Green WR, Vogelsang GB, Santos GW. The eye in bone marrow transplantation. VI. retinal complications. Arch Ophthalmol. 1994, 112:372-9. 10.1001\/archopht.1994.01090150102031","journal-title":"Arch Ophthalmol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-013-2301-z","article-title":"Graft versus host disease: clinical evaluation, diagnosis and management","volume":"251","author":"Espana EM","year":"2013","unstructured":"Espana EM, Shah S, Santhiago MR, Singh AD. Graft versus host disease: clinical evaluation, diagnosis and management. Graefes Arch Clin Exp Ophthalmol. 2013, 251:1257-66. 10.1007\/s00417-013-2301-z","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.41038","article-title":"Topical spironolactone in the treatment of evaporative dry eye disease","volume":"15","author":"Wong CW","year":"2023","unstructured":"Wong CW, Wong BS, Ali W, De Jesus ML, Melber TA, Yee RW. Topical spironolactone in the treatment of evaporative dry eye disease. Cureus. 2023, 15:e41038. 10.7759\/cureus.41038","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-0528","article-title":"Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line","volume":"46","author":"Robertson DM","year":"2005","unstructured":"Robertson DM, Li L, Fisher S, et al.. Characterization of growth and differentiation in a telomerase-immortalized human corneal epithelial cell line. Invest Ophthalmol Vis Sci. 2005, 46:470-8. 10.1167\/iovs.04-0528","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.107776","article-title":"Vitamin D receptor and metabolite effects on corneal epithelial cell gap junction proteins","volume":"187","author":"Lu X","year":"2019","unstructured":"Lu X, Chen Z, Vick S, Watsky MA. Vitamin D receptor and metabolite effects on corneal epithelial cell gap junction proteins. Exp Eye Res. 2019, 187:107776. 10.1016\/j.exer.2019.107776","journal-title":"Exp Eye Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/srep03419","article-title":"International chronic ocular graft-vs-host-disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (Part I)","volume":"3","author":"Ogawa Y","year":"2013","unstructured":"Ogawa Y, Kim SK, Dana R, et al.. International chronic ocular graft-vs-host-disease (GVHD) consensus group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep. 2013, 3:3419. 10.1038\/srep03419","journal-title":"Sci Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.04.037","article-title":"Proposed diagnostic criteria for obstructive meibomian gland dysfunction","volume":"116","author":"Arita R","year":"2009","unstructured":"Arita R, Itoh K, Maeda S, et al.. Proposed diagnostic criteria for obstructive meibomian gland dysfunction. Ophthalmology. 2009, 116:2058-63.e1. 10.1016\/j.ophtha.2009.04.037","journal-title":"Ophthalmology"},{"key":"ref13","article-title":"Safety and efficacy of a new eye drop formulation of spironolactone in a rat model of glucocorticoid-induced delay in corneal wound healing","volume":"64","author":"Rodrigues-Braz D","year":"2023","unstructured":"Rodrigues-Braz D, Zhu L, G\u00e9liz\u00e9 E, et al.. Safety and efficacy of a new eye drop formulation of spironolactone in a rat model of glucocorticoid-induced delay in corneal wound healing. Invest Ophthalmol Vis Sci. 2023, 64:1394.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref14","article-title":"Effects of spironolactone on corneal epithelium may contribute to beneficial dry eye effects","volume":"61","author":"Watsky MA","year":"2020","unstructured":"Watsky MA, Lu X, Chen Z, Yee R. Effects of spironolactone on corneal epithelium may contribute to beneficial dry eye effects. Invest Ophthalmol Vis Sci. 2020, 61:151.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.48.637","article-title":"Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1)","volume":"48","author":"Takahashi T","year":"2007","unstructured":"Takahashi T, Ono H, Ono Y, Ishimitsu T, Matsuoka H. Combination therapy with telmisartan and spironolactone alleviates L-NAME exacerbated nephrosclerosis with an increase in PPAR-gamma and decrease in TGF-beta(1). Int Heart J. 2007, 48:637-47. 10.1536\/ihj.48.637","journal-title":"Int Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3159","article-title":"PPAR\u03b3 signaling and metabolism: the good, the bad and the future","volume":"19","author":"Ahmadian M","year":"2013","unstructured":"Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, Evans RM. PPAR\u03b3 signaling and metabolism: the good, the bad and the future. Nat Med. 2013, 19:557-66. 10.1038\/nm.3159","journal-title":"Nat Med"},{"key":"ref17","article-title":"Potential mechanisms of action of mineralocorticoid receptor antagonists in a rat model of corneal neovascularization","volume":"64","author":"Zhao M","year":"2023","unstructured":"Zhao M, Rodrigues-Braz D, Yesilirmak N, G\u00e9liz\u00e9 E, Bourges J-L, Behar-Cohen FF. Potential mechanisms of action of mineralocorticoid receptor antagonists in a rat model of corneal neovascularization. Invest Ophthalmol Vis Sci. 2023, 64:1938.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2022.0174","article-title":"Topical losartan: Practical guidance for clinical trials in the prevention and treatment of corneal scarring fibrosis and other eye diseases and disorders","volume":"39","author":"Wilson SE","year":"2023","unstructured":"Wilson SE. Topical losartan: Practical guidance for clinical trials in the prevention and treatment of corneal scarring fibrosis and other eye diseases and disorders. J Ocul Pharmacol Ther. 2023, 39:191-206. 10.1089\/jop.2022.0174","journal-title":"J Ocul Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2022.108940","article-title":"Topical losartan inhibits corneal scarring fibrosis and collagen type IV deposition after Descemet's membrane-endothelial excision in rabbits","volume":"216","author":"Sampaio LP","year":"2022","unstructured":"Sampaio LP, Hilgert GS, Shiju TM, Murillo SE, Santhiago MR, Wilson SE. Topical losartan inhibits corneal scarring fibrosis and collagen type IV deposition after Descemet's membrane-endothelial excision in rabbits. Exp Eye Res. 2022, 216:108940. 10.1016\/j.exer.2022.108940","journal-title":"Exp Eye Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9970922","article-title":"Ocular distribution of the renin-angiotensin-aldosterone system in the context of the SARS-CoV-2 pandemic","volume":"2022","author":"Abid A","year":"2022","unstructured":"Abid A, Khan MA, Lee B, White A, Carnt N, Arshad S, Samarawickrama C. Ocular distribution of the renin-angiotensin-aldosterone system in the context of the SARS-CoV-2 pandemic. J Renin Angiotensin Aldosterone Syst. 2022, 2022:9970922. 10.1155\/2022\/9970922","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000586","article-title":"Tissue renin-angiotensin system in lacrimal gland fibrosis in a murine model of chronic graft-versus-host disease","volume":"34","author":"Yaguchi S","year":"2015","unstructured":"Yaguchi S, Ogawa Y, Kawakita T, Shimmura S, Tsubota K. Tissue renin-angiotensin system in lacrimal gland fibrosis in a murine model of chronic graft-versus-host disease. Cornea. 2015, 34:S142-52. 10.1097\/ICO.0000000000000586","journal-title":"Cornea"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22116114","article-title":"Cascade of inflammatory, fibrotic processes, and stress-induced senescence in chronic GVHD-related dry eye disease","volume":"22","author":"Ogawa Y","year":"2021","unstructured":"Ogawa Y, Kawakami Y, Tsubota K. Cascade of inflammatory, fibrotic processes, and stress-induced senescence in chronic GVHD-related dry eye disease. Int J Mol Sci. 2021, 22:10.3390\/ijms22116114","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-23750","article-title":"Sj\u00f6gren\u2019s syndrome, non-Sj\u00f6gren\u2019s Syndrome, and graft-versus-host disease related dry eye","volume":"59","author":"Ogawa Y","year":"2018","unstructured":"Ogawa Y. Sj\u00f6gren\u2019s syndrome, non-Sj\u00f6gren\u2019s Syndrome, and graft-versus-host disease related dry eye. Invest Ophthalmol Vis Sci. 2018, 59:DES71-9. 10.1167\/iovs.17-23750","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1210\/endo.143.5.8821","article-title":"Cyclosporine A and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation","volume":"143","author":"Deppe CE","year":"2002","unstructured":"Deppe CE, Heering PJ, Viengchareun S, Grabensee B, Farman N, Lomb\u00e8s M\r\n. Cyclosporine A and FK506 inhibit transcriptional activity of the human mineralocorticoid receptor: a cell-based model to investigate partial aldosterone resistance in kidney transplantation. Endocrinology. 2002, 143:1932-1941. 10.1210\/endo.143.5.8821","journal-title":"Endocrinology"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2012.08.004","article-title":"Ocular graft-versus-host disease: a review","volume":"58","author":"Shikari H","year":"2013","unstructured":"Shikari H, Antin JH, Dana R. Ocular graft-versus-host disease: a review. Surv Ophthalmol. 2013, 58:233-51. 10.1016\/j.survophthal.2012.08.004","journal-title":"Surv Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/181676-topical-spironolactone-in-the-treatment-of-ocular-graft-versus-host-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:57:55Z","timestamp":1707508675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/181676-topical-spironolactone-in-the-treatment-of-ocular-graft-versus-host-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.45136","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,12]]}}}